These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7851142

  • 1. [Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors].
    Hölting T, Duh OY, Clark OH, Herfarth C.
    Chirurg; 1994 Dec; 65(12):1100-6. PubMed ID: 7851142
    [Abstract] [Full Text] [Related]

  • 2. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.
    Hoelting T, Zielke A, Siperstein AE, Clark OH, Duh QY.
    Clin Exp Metastasis; 1994 Jul; 12(4):315-23. PubMed ID: 8039305
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
    Hölting T, Zielke A, Siperstein AE, Clark OH, Duh QY.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
    [Abstract] [Full Text] [Related]

  • 4. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
    Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH.
    Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
    Hoelting T, Siperstein AE, Clark OH, Duh QY.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
    [Abstract] [Full Text] [Related]

  • 6. Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).
    Hoelting T, Goretzki PE, Duh QY.
    Oncol Rep; 2001 Aug; 8(1):3-8. PubMed ID: 11115561
    [Abstract] [Full Text] [Related]

  • 7. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion.
    Zielke A, Hoffmann S, Plaul U, Duh QY, Clark OH, Rothmund M.
    Exp Clin Endocrinol Diabetes; 1999 Aug; 107(6):361-9. PubMed ID: 10543413
    [Abstract] [Full Text] [Related]

  • 8. Expression and secretion of endostatin in thyroid cancer.
    Hoffmann S, Wunderlich A, Lingelbach S, Musholt PB, Musholt TJ, von Wasielewski R, Zielke A.
    Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
    [Abstract] [Full Text] [Related]

  • 9. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T, Duh QY, Clark OH, Herfarth C.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Dec; 115(Suppl I):281-4. PubMed ID: 14518260
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
    Hoelting T, Siperstein AE, Duh QY, Clark OH.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
    Hoelting T, Duh QY, Clark OH, Herfarth C.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation.
    Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH.
    Biochem Biophys Res Commun; 1993 Sep 30; 195(3):1230-6. PubMed ID: 8216254
    [Abstract] [Full Text] [Related]

  • 13. The regulation of proliferation and invasion in differentiated thyroid cancer by growth factors.
    Hoelting T, Duh QY, Clark OH, Herfarth C.
    Exp Clin Endocrinol Diabetes; 1996 Sep 30; 104 Suppl 4():29-31. PubMed ID: 8980996
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC, Bedard YC, Rosen IB.
    J Am Coll Surg; 2004 Mar 30; 198(3):341-8. PubMed ID: 14992733
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
    Machens A, Holzhausen HJ, Dralle H.
    Cancer; 2005 Jun 01; 103(11):2269-73. PubMed ID: 15856429
    [Abstract] [Full Text] [Related]

  • 16. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC, Bedard YC, Rosen IB.
    Am Surg; 2007 May 01; 73(5):484-91. PubMed ID: 17521005
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E.
    Cell Growth Differ; 1995 Dec 01; 6(12):1635-42. PubMed ID: 9019169
    [Abstract] [Full Text] [Related]

  • 18. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S, Huang F, Hafez M, Winawer S, Friedman E.
    Cell Growth Differ; 1994 Mar 01; 5(3):267-75. PubMed ID: 8018559
    [Abstract] [Full Text] [Related]

  • 19. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD.
    Pathology; 2002 Jun 01; 34(3):239-44. PubMed ID: 12109784
    [Abstract] [Full Text] [Related]

  • 20. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E, Heitz PU, Martina B, Schweizer I.
    Praxis (Bern 1994); 2000 Nov 02; 89(44):1779-97. PubMed ID: 11109916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.